For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Aurobindo Pharma continues good show; scrip hits 52-week high

By Religare
|

Aurobindo Pharma continues good show; scrip hits 52-week high
Shares of drug maker Aurobindo Pharma extended gain over 5 per cent in early trade on Bombay Stock Exchange (BSE) with the stock touching 52-week high as investors continued to bet on companies robust performance.
 

The company had reported a robust operating performance for the second quarter ended September 2013 and had also received the final approval from the U.S. health regulator to manufacture and market DuloxetineHydrochloride Delayed-Release capsules, an anti-depressant drug, in the American market.

Continuing its gaining momentum, shares of company gained as much as 5.47 per cent to trade at Rs 404.80 a piece on the BSE.

In a similar fashion, shares of the company advanced 4.43 per cent 400.80 a piece on National Stock Exchange.

Meanwhile, the broader benchmark Sensex was quoting at 21,124.39, down 23.36 points or 0.11 per cent at 10:12 hours.

Dion Global Solutions Ltd.

Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more